{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:57:42Z","timestamp":1786993062988,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jneuroim.2025.578735","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T23:41:16Z","timestamp":1756165276000},"page":"578735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serum from patients with MuSK antibody-positive myasthenia gravis triggers transcriptomic changes leading to muscle atrophy and weakness in human myotube cells"],"prefix":"10.1016","volume":"408","author":[{"given":"Keisuke","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyuki","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manato","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Akamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Ogaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Nakatake-Furuie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshichika","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Serizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2025.578735_bb0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.08.016","article-title":"MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo","volume":"170","author":"Benveniste","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2025.578735_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2006.05.017","article-title":"Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis","volume":"177","author":"Boneva","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2025.578735_bb0015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3389\/fimmu.2020.00707","article-title":"Muscle-specific kinase Myasthenia gravis","volume":"11","author":"Borges","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578735_bb0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1749-6632.2012.06812.x","article-title":"The MG composite: an outcome measure for myasthenia gravis for use in clinical trials and everyday practice","volume":"1274","author":"Burns","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2025.578735_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fnmol.2020.00159","article-title":"Myasthenia gravis with antibodies against muscle specific kinase: an update on clinical features, pathophysiology and treatment","volume":"13","author":"Cao","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578735_bb0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/CCM.0b013e31822d7c18","article-title":"Muscle atrophy and preferential loss of myosin in prolonged critically ill patients","volume":"40","author":"Derde","year":"2012","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578735_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells13060556","article-title":"MuSK myasthenia gravis-potential pathomechanisms and treatment directed against specific targets","volume":"13","author":"Dziadkowiak","year":"2024","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578735_bb0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0960-8966(96)00009-0","article-title":"Clinical heterogeneity of seronegative myasthenia gravis","volume":"6","author":"Evoli","year":"1996","journal-title":"Neuromuscul. Disord."},{"issue":"Pt 10","key":"10.1016\/j.jneuroim.2025.578735_bb0045","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578735_bb0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/nyas.13518","article-title":"Myasthenia gravis with antibodies to MuSK: an update","volume":"1412","author":"Evoli","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Pt 6","key":"10.1016\/j.jneuroim.2025.578735_bb0055","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2025.578735_bb0060","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2007.01.010","article-title":"Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures","volume":"185","author":"Farrugia","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"26","key":"10.1016\/j.jneuroim.2025.578735_bb0065","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.jneuroim.2025.578735_bb0070","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578735_bb0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578735_bb0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1085\/jgp.200709790","article-title":"Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling","volume":"130","author":"Goonasekera","year":"2007","journal-title":"J. Gen. Physiol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578735_bb0085","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578735_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101268","article-title":"SERCA2a overexpression improves muscle function in a canine Duchenne muscular dystrophy model","volume":"32","author":"Kodippili","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"12","key":"10.1016\/j.jneuroim.2025.578735_bb0095","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1007\/s00415-021-10603-9","article-title":"MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation","volume":"268","author":"Konig","year":"2021","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578735_bb0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kramer","year":"2014","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578735_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2990.2008.00965.x","article-title":"Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR","volume":"35","author":"Martignago","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578735_bb0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jcb.21833","article-title":"Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes","volume":"105","author":"Menconi","year":"2008","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578735_bb0115","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/jnnp.2008.163485","article-title":"Bilateral hypogeusia in a patient with a unilateral paramedian thalamic infarction","volume":"81","author":"Nakajima","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578735_bb0120","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2007.01870.x","article-title":"Clinical and experimental features of MuSK antibody positive MG in Japan","volume":"14","author":"Ohta","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578735_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578735_bb0130","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","article-title":"Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways","volume":"3","author":"Rommel","year":"2001","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578735_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0606","article-title":"Mechanisms of glucocorticoid-induced myopathy","volume":"197","author":"Schakman","year":"2008","journal-title":"J. Endocrinol."},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578735_bb0140","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3390\/biom13091354","article-title":"The effect of SERCA activation on functional characteristics and signaling of rat soleus muscle upon 7 days of unloading","volume":"13","author":"Sharlo","year":"2023","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578735_bb0145","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ceca.2010.11.012","article-title":"The role of store-operated calcium influx in skeletal muscle signaling","volume":"49","author":"Stiber","year":"2011","journal-title":"Cell Calcium"},{"issue":"43","key":"10.1016\/j.jneuroim.2025.578735_bb0150","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578735_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123583","article-title":"The effect of SERCA1b silencing on the differentiation and calcium homeostasis of C2C12 skeletal muscle cells","volume":"10","author":"Toth","year":"2015","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578735_bb0160","article-title":"A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs","volume":"2","author":"Uchimura","year":"2021","journal-title":"Cell Rep. Med."},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578735_bb0165","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00234-021-02753-4","article-title":"MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis","volume":"63","author":"Velonakis","year":"2021","journal-title":"Neuroradiology"},{"issue":"7","key":"10.1016\/j.jneuroim.2025.578735_bb0170","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578735_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13395-021-00280-7","article-title":"The SarcoEndoplasmic reticulum calcium ATPase (SERCA) pump: a potential target for intervention in aging and skeletal muscle pathologies","volume":"11","author":"Xu","year":"2021","journal-title":"Skelet. Muscle"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578735_bb0180","doi-asserted-by":"crossref","first-page":"C323","DOI":"10.1152\/ajpcell.00393.2012","article-title":"Distinct and additive effects of sodium bicarbonate and continuous mild heat stress on fiber type shift via calcineurin\/NFAT pathway in human skeletal myoblasts","volume":"305","author":"Yamaguchi","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jneuroim.2025.578735_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578205","article-title":"Serum cytokine profiles in myasthenia gravis with anti-muscle-specific kinase antibodies","volume":"384","author":"Yasuda","year":"2023","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578735_bb0190","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1552-6569.2009.00456.x","article-title":"MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis","volume":"21","author":"Zouvelou","year":"2011","journal-title":"J. Neuroimaging"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825002164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825002164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:34:22Z","timestamp":1782261262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825002164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":38,"alternative-id":["S0165572825002164"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578735","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum from patients with MuSK antibody-positive myasthenia gravis triggers transcriptomic changes leading to muscle atrophy and weakness in human myotube cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578735"}}